지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학위논문
- 저자정보
- 지도교수
- 김경민
- 발행연도
- 2018
- 저작권
- 동의대학교 논문은 저작권에 의해 보호받습니다.
이용수4
이 논문의 연구 히스토리 (2)
- 이 논문의 후속연구가 궁금하신가요?
- 연관 학술논문 또는 학술발표를 통해 보다 발전된 연구결과를 확인하실 수 있습니다.
- 이 논문의 연구 히스토리 확인하기
초록· 키워드
오류제보하기
본 연구는 중풍 후 딸꾹질의 한약치료의 최신 연구 동향을 파악하기 위하여 中國知識基礎施設(China National Knowledge Infrastructure : CNKI) 검색을 통해 2006년 1월 이후부터 출간된 중국 임상 논문 22편을 분석하여 다음과 같은 결론을 얻었다.
처방 중 가장 많이 사용된 것은 旋覆代?湯(6편)이었다. 처방된 탕약 중 다용 약재는 代?石, 半夏, 旋覆花가 총 17회로 가장 많았다. 치료의 효과는 모든 논문에서 임상증상에 따라 유효율을 평가하였다. 그 외 부작용 반응 발생률, 재발률, 식이섭취, 치료효과가 나타나기까지 걸린 시간, 환자 만족도 등이 평가되었다. 치료군의 총유효율은 치료군 86.36-97.78%로, 대조군이 있는 모든 연구에서 대조군에 비해 치료군에서 높은 총 유효율을 보였으며, 유의한 차이를 나타냈다.
22편의 연구에서 중풍 후 딸꾹질의 한약 치료는 유의한 치료 효과를 나타냈다. 추가적인 연구들이 이루어져야할 것으로 생각되며, 본 연구의 결과가 향후 연구에서 기초 자료로 활용될 수 있을 것이다.
처방 중 가장 많이 사용된 것은 旋覆代?湯(6편)이었다. 처방된 탕약 중 다용 약재는 代?石, 半夏, 旋覆花가 총 17회로 가장 많았다. 치료의 효과는 모든 논문에서 임상증상에 따라 유효율을 평가하였다. 그 외 부작용 반응 발생률, 재발률, 식이섭취, 치료효과가 나타나기까지 걸린 시간, 환자 만족도 등이 평가되었다. 치료군의 총유효율은 치료군 86.36-97.78%로, 대조군이 있는 모든 연구에서 대조군에 비해 치료군에서 높은 총 유효율을 보였으며, 유의한 차이를 나타냈다.
22편의 연구에서 중풍 후 딸꾹질의 한약 치료는 유의한 치료 효과를 나타냈다. 추가적인 연구들이 이루어져야할 것으로 생각되며, 본 연구의 결과가 향후 연구에서 기초 자료로 활용될 수 있을 것이다.
목차
Ⅰ. 서론 ································································································ 1Ⅱ. 연구 대상 및 방법 ····································································· 31. 논문의 검색 ················································································· 32. 논문의 선별 ················································································· 33. 자료의 정리 ················································································· 4Ⅲ. 결과 ······························································································ 101. 연도별 분포 ··············································································· 102. 연구방법 분석 ··········································································· 103. 연구대상 분석 ··········································································· 114. 치료방법 ····················································································· 125. 변증분류에 따른 약물가감 ····················································· 146. 치료기간 ····················································································· 167. 추적기간 ····················································································· 178. 치료효과의 평가 ······································································· 179. 치료결과 ····················································································· 18Ⅳ. 고찰 ······························································································ 19Ⅴ. 결론 ······························································································ 26
최근 본 자료
댓글(0)
0